Literature DB >> 24126343

Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema.

Takumi Yamamoto1, Mitsunaga Narushima, Hidehiko Yoshimatsu, Nana Yamamoto, Aiko Oka, Yukio Seki, Takeshi Todokoro, Takuya Iida, Isao Koshima.   

Abstract

Lymph transportation capacity is a critical function maintaining fluid circulation. After pelvic cancer treatments, lymph obstruction at the pelvic region leads to abnormal lymph circulation, resulting in lymph pump dysfunction. Besides lymph circulation, lymph pump function is important for lymphedema evaluation. We assessed and analyzed lymph transportation capacity of secondary lower extremity lymphedema patients using indocyanine green (ICG) lymphography according to corresponding severity stage. Indocyanine green velocity and transit time could evaluate lymph pump function; ICG velocity decreases and transit time increases as the lymphedema severity stage progresses. Measurement of ICG velocity required 5 minutes after the dye injection, whereas that of transit time took more than 1 hour in severe cases. Indocyanine green velocity can be easily obtained and is recommended for evaluation of lymph pump function compared with transit time. Dynamic ICG lymphography, which evaluates both lymph pump function and circulation, plays an important role in comprehensive assessment of lymphedema pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126343     DOI: 10.1097/SAP.0b013e318255168a

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  8 in total

Review 1.  Supermicrosurgery for oncologic reconstructions.

Authors:  Takumi Yamamoto; Nana Yamamoto; Takashi Kageyama; Hayahito Sakai; Yuma Fuse; Kanako Tsuihiji; Reiko Tsukuura
Journal:  Glob Health Med       Date:  2020-02-29

Review 2.  Lymphedema secondary to melanoma treatments: diagnosis, evaluation, and treatments.

Authors:  Azuelos Arié; Takumi Yamamoto
Journal:  Glob Health Med       Date:  2020-08-31

3.  Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema.

Authors:  Joseph Kyu-Hyung Park; Junggyo Seo; Eun Joo Yang; Yusuhn Kang; Chan Yeong Heo; Yujin Myung
Journal:  Breast Cancer       Date:  2022-05-12       Impact factor: 3.307

4.  Treatment of Early-Stage Gynecological Cancer-Related Lower Limb Lymphedema by Lymphaticovenular Anastomosis-The Triple Incision Approach.

Authors:  Anna Amelia Caretto; Gianluigi Stefanizzi; Giorgia Garganese; Simona Maria Fragomeni; Alex Federico; Luca Tagliaferri; Bruno Fionda; Alessandro Cina; Giovanni Scambia; Stefano Gentileschi
Journal:  Medicina (Kaunas)       Date:  2022-05-01       Impact factor: 2.948

5.  Effect of pneumatic compression therapy on lymph movement in lymphedema-affected extremities, as assessed by near-infrared fluorescence lymphatic imaging.

Authors:  Melissa B Aldrich; Deborah Gross; John Rodney Morrow; Caroline E Fife; John C Rasmussen
Journal:  J Innov Opt Health Sci       Date:  2016-09-28

6.  Quantitative Contrast-Enhanced Magnetic Resonance Lymphangiography of the Upper Limbs in Breast Cancer Related Lymphedema: An Exploratory Study.

Authors:  Marco Borri; Maria A Schmidt; Kristiana D Gordon; Toni A Wallace; Julie C Hughes; Erica D Scurr; Dow-Mu Koh; Martin O Leach; Peter S Mortimer
Journal:  Lymphat Res Biol       Date:  2015-03-16       Impact factor: 2.589

7.  HAMAMATSU-ICG study: Protocol for a phase III, multicentre, single-arm study to assess the usefulness of indocyanine green fluorescent lymphography in assessing secondary lymphoedema.

Authors:  Shinsuke Akita; Naoki Unno; Jiro Maegawa; Yoshihiro Kimata; Hidekazu Fukamizu; Yuichiro Yabuki; Akira Shinaoka; Masaki Sano; Yohei Kawasaki; Tadami Fujiwara; Hideki Hanaoka; Nobuyuki Mitsukawa
Journal:  Contemp Clin Trials Commun       Date:  2020-06-16

8.  Side-to-end Lymphaticovenular anastomosis through temporary lymphatic expansion.

Authors:  Takumi Yamamoto; Hidehiko Yoshimatsu; Nana Yamamoto; Mitsunaga Narushima; Takuya Iida; Isao Koshima
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.